(0.86%) 5 248.49 points
(1.22%) 39 760 points
(0.51%) 16 400 points
(1.27%) $82.38
(0.81%) $1.732
(1.74%) $2 228.80
(-0.05%) $24.74
(0.87%) $917.60
(0.22%) $0.925
(0.56%) $10.83
(0.00%) $0.791
(0.10%) $92.53
Live Chart Being Loaded With Signals
Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths...
Stats | |
---|---|
Today's Volume | 513.00 |
Average Volume | 82.00 |
Market Cap | 5.80M |
EPS | $-0.0200 ( 2023-11-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.250 |
ATR14 | $0 (0.00%) |
Sigyn Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sigyn Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-8 856.00 (0.00 %) |
EPS: | $-3.77 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-1 610.00 (0.00 %) |
EPS: | $-0.940 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-2 016.00 (0.00 %) |
EPS: | $-0.0205 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-2 615.00 (0.00 %) |
EPS: | $-0.0167 |
Financial Reports:
No articles found.
Sigyn Therapeutics, Inc.
Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators